[Market Feature] PharmaResearch Rises 5% on Balanced Growth Outlook in Domestic and Overseas Markets
On January 9, PharmaResearch showed strong gains in early trading. The buying momentum is believed to have been driven by securities firms' outlook for high growth in overseas sales.
As of 9:34 a.m. that day, PharmaResearch was trading at 487,500 won, up 25,000 won (5.41%) from the previous session.
Kiwoom Securities released a report that day, forecasting strong fourth-quarter results for PharmaResearch. The company projected sales of 152.7 billion won, up 48.1% year-on-year, and operating profit of 61.7 billion won, up 83% over the same period.
Shin Minsoo, a researcher at Kiwoom Securities, explained, “Both domestic growth and exports of ‘Rejuran’ are progressing evenly, which will drive continued quarter-on-quarter growth. Cosmetics are also expected to post growth of more than 60% year-on-year across all borders, further solidifying the position of the ‘Rejuran’ brand.”
Researcher Shin maintained a “Buy” investment opinion on PharmaResearch and a target price of 700,000 won.
Jung Heeryeong, a researcher at Kyobo Securities, stated in a report that day, “Domestic medical device performance has recovered compared to the previous quarter, and the sluggish domestic demand in the third quarter was proven to be affected by the medical strike. In 2026, new growth drivers are expected to lead high growth, including the start of exports to new countries such as Europe, the early stage of cosmetics growth in the United States, and additional momentum from new markets outside existing export destinations like the Middle East and South America.”
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Researcher Jung added, “The stock began to rebound on expectations of export-import data for December and fourth-quarter results. With a 2026 P/E ratio of 20 times, the stock is entering a period of attractive valuation,” maintaining a “Buy” recommendation and a target price of 800,000 won.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.